Traders Moved These 13 Stocks On Monday’s CNBC’s ‘Fast Money: Halftime Report’
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Cameco Shares Could Continue Their Upward Trajectory
Shares of Cameco Corp (NYSE: CCJ) Tuesday climbed over 1% on Tuesday, adding to recent gains and taking the stock higher by more than 36% year to date.
Ukraine War Has Uranium Prices Soaring, Analyst Says Buy This Uranium Producer
Uranium prices have skyrocketed since Russia invaded Ukraine, and one analyst said Tuesday that investors can expect upward pricing pressure on uranium to persist for the foreseeable future.
Here’s How Much $100 Invested In Cameco 20 Years Ago Would Be Worth Today
Cameco (NYSE:CCJ) has outperformed the market over the past 20 years by 2.22% on an annualized basis producing an average annual return of 9.42%. Currently, Cameco has a market capitalization of $11.54 billion.
Uranium Projections Give This Cameco Analyst A Certain Glow
Declining global uranium inventory levels may lend upside support to Cameco Corp.’s (NYSE: CCJ) stock, according to BMO Capital Markets.
The Cameco Analyst: Alexander Pearce upgraded the rating for Cameco to Outperform, while raising the price target to C$42 (U.S.$33.63).
Jim Cramer Recommends Buying This Stock Ahead Of Earnings
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Huntington Bancshares Incorporated (NASDAQ: HBAN) very much.
CNBC’s Final Trades: HealthEquity, Carlyle, Cameco, Citigroup And This Retailer
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said HealthEquity Inc’s (NASDAQ: HQY) stock had “a terrible year” in 2021.
Uranium Stocks With Another Strong Day Of Trading Amid Reports Wednesday, Thursday ‘Senate Republicans seek Russian uranium ban’
https://www.washingtontimes.com/news/2022/mar/16/john-barrasso-others-seek-russian-uranium-ban/?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork